Optimizing Bispecific Antibody Treatment for Non-Hodgkin Lymphoma: Current Best Practices for Mitigating and Managing Cytokine Release Syndrome (Ask-the-Experts)
Event Date/Time
Wednesday, September 3, 2025
2:00-3:30 PM ET
Audience Event Link: https://event.webcasts.com/starthere.jsp?ei=1718911&tp_key=b05a628c9a
Wednesday, September 17, 2025
3:00-4:30 PM ET
Audience Event Link: https://event.webcasts.com/starthere.jsp?ei=1718914&tp_key=5279da37be
Location
From the convenience of your home or business; accessible via both PC and MAC
Fee
Free. There is no fee for this educational activity.
Type of Activity
Application.
Estimated Time to Complete Activity
90 minutes
Specialty
Hematology-Oncology
Topics
Oncology
Credit Available
- Nurses
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours. Designated contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses pending. - Pharmacists, please proceed to PowerPak/PHE to complete the activity and claim credit.
- Sept 3, 2025: https://www.powerpak.com/course/preamble/126828
- Sept 17, 2025: https://www.powerpak.com/course/preamble/126829
Program Overview
The goal of this educational activity is to equip and empower oncology pharmacists, nurse practitioners (NPs), and nurses with the knowledge, competence, and confidence they need to ensure the safe and effective use of bispecific antibodies (BsAbs) for patients with B-cell non-Hodgkin lymphoma, with a particular emphasis on best practice monitoring, mitigation, and collaborative management of BsAb-associated cytokine release syndrome within integrated clinical workflows and logistical frameworks.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Describe the prevalence, practice gaps, and traditional standard of care treatment for B-cell non-Hodgkin lymphoma (B-NHL)
- Evaluate the trial evidence and regulatory milestones for CD3xCD20 bispecific antibodies (BsAbs) in B-NHL, with a focus on BsAb-associated cytokine release syndrome (CRS)
- Explain the mechanisms involved in hypertriglyceridemic pancreatitis and demonstrate the steps for accurate diagnosis and appropriate treatment.
- Design coordinated care plans to monitor, mitigate, and manage CRS, ICANS, and late toxicities in patients receiving BsAbs for B-NHL in accordance with current expert consensus guidance
Agenda
Introduction (5 minutes)
Presentation (70 minutes)
Conclusions & Question & Answer Session (15 minutes)
Faculty
Issam S. Hamadeh, PharmD
Clinical Pharmacy Specialist
Memorial Sloan Kettering Cancer Center
New York, NY
Katherine Byar, MSN, APN, BC, BMTCN®
Hematological Malignancy Nurse Practitioner
Oncology/Hematology
Fred & Pamela Buffett Cancer Center
Omaha, Nebraska
Accreditation Statements
PHARMACY
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council
for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 0430-9999-25-045-L01-P
Credits: 1.5 hour (0.15 ceu)
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Postgraduate Healthcare Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours. Designated contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses pending.
Disclosures of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
How To Earn Credit
Participants must 1) read the learning objectives and faculty disclosures; 2) attend and participate in the live event; and 3) complete the posttest and evaluation form directly after the event with a maximum of within 60 days of attending the live session. To answer the questions, click on your selected choice for each answer then proceed to the next question. Your credit will automatically uploaded to CPE Monitor.
Required Computer Hardware/Software
Please ensure the computer system you plan to use meets the following minimum requirements:
- Operating System: Windows 98 or higher & Macintosh 2.2 or higher
- Internet Browser (Mac / Windows): Microsoft Edge, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
- Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
- Peripherals: Computer speakers or headphones
- Monitor Screen Resolution: 320 x 480 or higher
- Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, & HTML5